ArticleEndocrinology and metabolism (Seoul, Korea)2026
A Korean Clinical Practice Framework for Thyroid Eye Disease: Integrating International Recommendations with Survey-Informed Consensus.
Article in Endocrinology and metabolism (Seoul, Korea), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Orbital Radiotherapy for Thyroid-Associated Orbitopathy in the Era of Targeted Biologics: Reposition, Not Replace.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid eye disease (TED), the most common extrathyroidal manifestation of Graves' disease, requires individualized management that integrates medical, radiotherapeutic, and surgical interventions. In this article, we present a society-endorsed, survey-informed Korean clinical practice framework, including consensus elements, for TED management. This framework integrates the 2022 American Thyroid Association/European Thyroid Association consensus, the 2021 European Group on Graves' Orbitopathy (EUGOGO) guideline, and contemporary Korean specialist practice patterns. A 2025 nationwide survey of 32 members of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery characterized current Korean practice patterns in TED management. Korean oculoplastic surgeons showed high adherence to international recommendations, with 87.5% using both the clinical activity score and EUGOGO severity classification and 96.9% administering intravenous glucocorticoid therapy according to EUGOGO protocols. Distinctive features of Korean practice included frequent use of orbital radiotherapy (90.6%) and regional triamcinolone injections (81.2%) in selected clinical settings. For dysthyroid optic neuropathy, 59.4% of respondents reported using combined intravenous glucocorticoid therapy and orbital radiotherapy as the initial treatment approach. This framework stratifies treatment according to disease activity, severity, and predominant clinical phenotype to support context-adapted therapeutic decision-making. As emerging therapies such as teprotumumab become more accessible, this Korean clinical practice framework may provide practical guidance tailored to local clinical practice and healthcare-system constraints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.